Roche Completes $1.9-Billion Acquisition of Flatiron Health
Roche has completed its previously announced $1.9-billion acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York, NY, the pharma major announced on April 6, 2018.
Under the agreement, Flatiron Health will continue to operate as a separate legal entity, and its current business model, network of partnerships, and overall objectives remain. The integrity of segregated patient-protected health information will be preserved, as will sales, marketing, provider-facing, and life science business activities.
Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well as in the curation and development of real-world evidence for cancer research, Roche reports. Flatiron Health has created a technology platform designed to learn from the experience of every patient using a large network of community oncology practices and academic medical centers across the United States. The acquisition allows both companies to accelerate progress towards data-driven personalized healthcare in cancer.
Currently, Flatiron partners with more than 265 community cancer clinics, six major academic research centers, and 14 out of the top 15 therapeutic oncology companies.
Source: Roche
|
|---|
|
Current Issue
USP Proposes a New Chapter for Rapid Sterility Testing
The US Pharmacopeial Convention (USP) is developing a new chapter for rapid sterility testing of short-life products based on the recommendations of a panel of experts and stakeholders.
Study on an Inactivation Evaluation Method of Cleaning Processes for Biopharmaceuticals
This study was successful in establishing a reliable and effective method for evaluating cleaning processes based on risk.
Ensuring Viral Safety of Viral Vaccines and Vectors
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Outsourcing
Biopharma Demand Continues to Influence CMO Actions
Partnerships, mergers, and new services indicate that biologics are continuing to influence CMOs’ and CDMOs’ decisions to expand their biopharmaceutical services.
Be a Part of the Solution
Sharing of bioprocessing know-how can help resolve pressing industry problems.
SGS Increases Biopharma Characterization Capabilities
An expansion of laboratory facilities in Geneva, Switzerland expands SGS services for high-order structure analysis.
Sotera Health’s Nelson Labs Acquires Gibraltar Laboratories
The acquisition strengthens Nelson Labs’ outsourced testing capabilities for the pharmaceutical and medical device industries.
Standards/Regulations
USP Proposes a New Chapter for Rapid Sterility Testing
The US Pharmacopeial Convention (USP) is developing a new chapter for rapid sterility testing of short-life products based on the recommendations of a panel of experts and stakeholders.
Study on an Inactivation Evaluation Method of Cleaning Processes for Biopharmaceuticals
This study was successful in establishing a reliable and effective method for evaluating cleaning processes based on risk.
PDA’s New Technical Report Highlights Data Integrity Management System for Pharma Labs
PDA Technical Report 80 (TR 80): Data Integrity in Laboratory Systems is the first in a series of three technical reports PDA will publish on data integrity.
Sponsored Links
